{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:11:43Z","timestamp":1791357103936,"version":"4.3.1"},"reference-count":28,"publisher":"American Psychiatric Association Publishing","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP"],"published-print":{"date-parts":[[1999,2,1]]},"DOI":"10.1176\/ajp.156.2.299","type":"journal-article","created":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T12:17:10Z","timestamp":1659097030000},"page":"299-303","source":"Crossref","is-referenced-by-count":84,"title":["Diazepam Treatment of Early Signs of Exacerbation in Schizophrenia"],"prefix":"10.1176","volume":"156","author":[{"suffix":"Jr.","given":"William T.","family":"Carpenter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Buchanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Kirkpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan F.","family":"Breier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"230","reference":[{"key":"R15602BABDFDGF","doi-asserted-by":"crossref","unstructured":"Johns CA, Thompson JW: Adjunctive treatments in schizophrenia: pharmacotherapies and electroconvulsive therapy. Schizophr Bull 1995; 21:607\u2013619","DOI":"10.1093\/schbul\/21.4.607"},{"key":"atypb1","doi-asserted-by":"crossref","unstructured":"Kane JM: Schizophrenia. N Engl J Med 1996; 334:34\u201341","DOI":"10.1056\/NEJM199601043340109"},{"key":"atypb2","doi-asserted-by":"crossref","unstructured":"Christison GW, Kirch DG, Wyatt RJ: When symptoms persist: choosing among alternative somatic treatments for schizophrenia. Schizophr Bull 1991; 17:217\u2013245","DOI":"10.1093\/schbul\/17.2.217"},{"key":"atypb3","doi-asserted-by":"crossref","unstructured":"Meltzer HY: Treatment of the neuroleptic-nonresponsive schizo\u00adphrenic patient. Schizophr Bull 1995; 18:515\u2013542","DOI":"10.1093\/schbul\/18.3.515"},{"key":"atypb4","unstructured":"Siris SG, Adan F, Cohen M, Mandeli J, Aronson A, Fdasono-Dube B: Targeted treatment of depression-like symptoms in schizophrenia. Psychopharmacol Bull 1987; 23:85\u201389"},{"key":"R15602BABBCGCI","doi-asserted-by":"crossref","unstructured":"Siris SG, Bermanzohn PC, Mason SE, Shuwall MA: Antidepressant for substance abusing schizophrenia patients: a mini-review. Prog Neuropsychopharmacol Biol Psychiatry 1991; 15:1\u201313","DOI":"10.1016\/0278-5846(91)90036-Z"},{"key":"R15602BABDGACC","doi-asserted-by":"crossref","unstructured":"Goff DC, Tsai G, Manoach DS, Coyle JT: Dose-finding trial of  d-cycloserine added to neuroleptics for negative symptoms in schizophrenia. Am J Psychiatry 1995; 152:1213\u20131215","DOI":"10.1176\/ajp.152.8.1213"},{"key":"atypb5","doi-asserted-by":"crossref","unstructured":"Javitt DC, Zylberman I, Zukin SR, Heresco-Levy U, Lindenmayer J-P: Amelioration of negative symptoms in schizophrenia by glycine. Am J Psychiatry 1994; 151:1234\u20131236","DOI":"10.1176\/ajp.151.8.1234"},{"key":"atypb6","doi-asserted-by":"crossref","unstructured":"Leiderman E, Zylberman I, Zukin SR, Cooper TB, Javitt DC: Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open label trial. Biol Psychiatry 1996; 39:213\u2013215","DOI":"10.1016\/0006-3223(95)00585-4"},{"key":"R15602BABBIGII","doi-asserted-by":"crossref","unstructured":"Heresco-Levy U, Javitt DC, Irmilov M, Mordel C, Horowitz A, Kelly D: Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia. Br J Psychiatry 1996; 169:610\u2013617","DOI":"10.1192\/bjp.169.5.610"},{"key":"R15602BABBJHBA","doi-asserted-by":"crossref","unstructured":"Norman RMG, Malla AK: Prodromal symptoms of relapse in schizophrenia: a review. Schizophr Bull 1995; 21:527\u2013539","DOI":"10.1093\/schbul\/21.4.527"},{"key":"R15602BABDHEIC","doi-asserted-by":"crossref","unstructured":"Herz MI, Melville C: Relapse in schizophrenia. Am J Psychiatry 1980; 137:801\u2013805","DOI":"10.1176\/ajp.137.7.801"},{"key":"R15602BABCIJAH","doi-asserted-by":"crossref","unstructured":"Heinrichs DW, Carpenter WT: Prospective study of prodromal symptoms in schizophrenic relapse. Am J Psychiatry 1985; 142:371\u2013373","DOI":"10.1176\/ajp.142.3.371"},{"key":"R15602BABBIGIJ","doi-asserted-by":"crossref","unstructured":"Bustillo J, Buchanan RW, Carpenter WT: Prodromal symptoms vs early warning signs and clinical action in schizophrenia. Schizophr Bull 1995; 21:553\u2013561","DOI":"10.1093\/schbul\/21.4.553"},{"key":"R15602BABBIDFD","doi-asserted-by":"crossref","unstructured":"van Kammen DP: \u03b3-Aminobutyric acid (Gaba) and the dopamine hypothesis of schizophrenia. Am J Psychiatry 1977; 134:138\u2013143; correction, 134:463\u2013464","DOI":"10.1176\/ajp.134.2.138"},{"key":"R15602BABEACAE","doi-asserted-by":"crossref","unstructured":"Wolkowitz OM, Pickar D: Benzodiazepines in the treatment of schizophrenia: a review and reappraisal. Am J Psychiatry 1991; 148:714\u2013726","DOI":"10.1176\/ajp.148.6.714"},{"key":"R15602BABDICHD","unstructured":"Wolkowitz OM, Turetsky MA, Reus VI, Hargreaves WA: Benzodiazepine augmentation of neuroleptics in treatment-resistant schizophrenia. Psychopharmacol Bull 1992; 28:291\u2013295"},{"key":"R15602BABCHHDB","doi-asserted-by":"crossref","unstructured":"Kirkpatrick B, Buchanan RW, Waltrip RW, Jauch D, Carpenter WT: Diazepam treatment of early symptoms of schizophrenic relapse. J Nerv Ment Dis 1989; 177:52\u201353","DOI":"10.1097\/00005053-198901000-00009"},{"key":"R15602BABBJGEG","doi-asserted-by":"crossref","unstructured":"Hawk AB, Carpenter WT, Strauss JS: Diagnostic criteria and five-year outcome in schizophrenia. Arch Gen Psychiatry 1975; 32:343\u2013347","DOI":"10.1001\/archpsyc.1975.01760210077005"},{"key":"R15602BABCAJGE","doi-asserted-by":"crossref","unstructured":"Carpenter WT, Heinrichs DW: Early intervention, time-limited targeted pharmacotherapy in schizophrenia. Schizophr Bull 1983; 9:533\u2013542","DOI":"10.1093\/schbul\/9.4.533"},{"key":"R15602BABBBHFG","unstructured":"Carpenter WT, Heinrichs DW, Hanlon TE: A comparative trial of pharmacologic strategies in schizophrenia: a comparative study of new approaches. Psychopharmacol Bull 1986; 22:854\u2013859"},{"key":"R15602BABCJBAA","doi-asserted-by":"crossref","unstructured":"Carpenter WT Jr, Hanlon TE, Heinrichs DW, Summerfelt AT, Kirkpatrick B, Levine J, Buchanan RW: Continuous versus targeted medication in schizophrenic outpatients: outcome results. Am J Psychiatry 1990; 147:1138\u20131148","DOI":"10.1176\/ajp.147.9.1138"},{"key":"R15602BABBJEBB","doi-asserted-by":"crossref","unstructured":"Dixon LB, Lehman AF, Levine J: Conventional antipsychotic medications for schizophrenia. Schizophr Bull 1995; 21:567\u2013577","DOI":"10.1093\/schbul\/21.4.567"},{"key":"R15602BABECBFE","doi-asserted-by":"crossref","unstructured":"Weiden PJ, Olfson M: Cost of relapse in schizophrenia. Schizophr Bull 1995; 21:419\u2013429","DOI":"10.1093\/schbul\/21.3.419"},{"key":"R15602BABBIGJG","doi-asserted-by":"crossref","unstructured":"Lehman AF, Steinwachs DM, Survey Co-Investigators of the PORT Project: Patterns of usual care for schizophrenia: initial results from the schizophrenia patient outcomes research team (PORT) client survey. Schizophr Bull 1998; 24:11\u201320","DOI":"10.1093\/oxfordjournals.schbul.a033303"},{"key":"R15602BABCFEGI","doi-asserted-by":"crossref","unstructured":"Carpenter WT, Schooler NR, Kane JM: The rationale and ethics of medication-free research in schizophrenia. Arch Gen Psychiatry 1997; 54:401\u2013407","DOI":"10.1001\/archpsyc.1997.01830170015002"},{"key":"R15602BABBEGFE","doi-asserted-by":"crossref","unstructured":"Schooler NR, Keith SJ, Severe JB, Matthews SM, Bellack AS, Glick ID, Hargreaves WA, Kane JM, Ninan PT, Frances A, Jacobs M, Lieberman JA, Mance R, Simpson GM, Woerner MG: Relapse and rehospitalization during maintenance treatment of schizophrenia. Arch Gen Psychiatry 1997; 54:453\u2013464","DOI":"10.1001\/archpsyc.1997.01830170079011"},{"key":"R15602BABCEFFE","doi-asserted-by":"crossref","unstructured":"Carpenter WT Jr, Heinrichs DW, Hanlon TE: A comparative trial of pharmacologic strategies in schizophrenia. Am J Psychiatry 1987; 144:1466\u20131470","DOI":"10.1176\/ajp.144.11.1466"}],"container-title":["American Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ajp.psychiatryonline.org\/doi\/10.1176\/ajp.156.2.299","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T19:51:56Z","timestamp":1721850716000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/ajp.156.2.299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,2,1]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1999,2,1]]}},"alternative-id":["10.1176\/ajp.156.2.299"],"URL":"https:\/\/doi.org\/10.1176\/ajp.156.2.299","relation":{},"ISSN":["0002-953X","1535-7228"],"issn-type":[{"value":"0002-953X","type":"print"},{"value":"1535-7228","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,2,1]]}}}